Market Value4,714,958,000
Total Holdings97
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
GBT / Global Blood Therapeutics Inc.
IOVA / Iovance Biotherapeutics, Inc.
ALT / Altimmune, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
VIR / Vir Biotechnology, Inc.
GRTS / Gritstone bio, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
PHAS / PhaseBio Pharmaceuticals Inc
TIL / Instil Bio, Inc.
PANA / Panacea Acquisition Corp II - Class A
ABBV / AbbVie Inc.
S / SentinelOne, Inc.
EQRX / EQRx Inc
SPNE / SeaSpine Holdings Corp
DYNS / Dynamics Special Purpose Corp Class A
ZNTL / Zentalis Pharmaceuticals, Inc.
SIBN / SI-BONE, Inc.
AMN / AMN Healthcare Services, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
XBI / SPDR Series Trust - State Street SPDR S&P Biotech ETF Call
LSAQ / LifeSci Acquisition II Corp
HYPR / Hyperfine, Inc.
NBIX / Neurocrine Biosciences, Inc.
AVTR / Avantor, Inc.
ALPN / Alpine Immune Sciences, Inc.
XLRN / Acceleron Pharma Inc
XLRN / Acceleron Pharma Inc Call
DH / Definitive Healthcare Corp.
NUVB / Nuvation Bio Inc.
REGN / Regeneron Pharmaceuticals, Inc.
VRDN / Viridian Therapeutics, Inc.
BHVN / Biohaven Ltd.
BPMC / Blueprint Medicines Corporation
MLTX / MoonLake Immunotherapeutics
31656R102 / Field Trip Health Ltd. (Canada)
SGHT / Sight Sciences, Inc.
DNAB / Social Capital Suvretta Holdings Corp II
US83444K1135 / SomaLogic Inc
/ Nautilus Biotechnology Inc
ZETA / Zeta Global Holdings Corp.
ESMT / EngageSmart, Inc.
LFST / LifeStance Health Group, Inc.
HCAQ / HealthCor Catalio Acquisition Corp - Class A
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
KYG5960S1241 / Medicus Sciences Acquisition Corp.
DNAC / Social Capital Suvretta Holdings Corp III
DNAA / Social Capital Suvretta Holdings Corp I
/ CareMax Inc
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
CMPX / Compass Therapeutics, Inc.
ZIOP / Alaunos Therapeutics Inc
PATH / UiPath, Inc.
SANA / Sana Biotechnology, Inc.
GHRS / GH Research PLC
MRUS / Merus N.V.
TRDA / Entrada Therapeutics, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
ATAI / AtaiBeckley Inc.
IMAB / I-Mab - Depositary Receipt (Common Stock)
HOWL / Werewolf Therapeutics, Inc.
TALS / Talaris Therapeutics Inc
STTK / Shattuck Labs, Inc.
SHC / Sotera Health Company
ARNA / Arena Pharmaceuticals Inc
GLUE / Monte Rosa Therapeutics, Inc.
SLGC / Standard BioTools Inc.
RLMD / Relmada Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
HOLX / Hologic, Inc.
INSM / Insmed Incorporated
ONCS / OncoSec Medical Inc
MRTX / Mirati Therapeutics, Inc.
OCDX / Ortho Clinical Diagnostics Holdings PLC
HZNP / Horizon Therapeutics Plc
BLSA / BCLS Acquisition Corp - Class A
HSAQ / Health Sciences Acquisitions Corp 2
STVN / Stevanato Group S.p.A.
CCXI / Churchill Capital Corp XI
HARP / Harpoon Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
DNAD / Social Capital Suvretta Holdings Corp IV - Class A
MSAC / Medicus Sciences Acquisition Corp - Class A
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
VRTX / Vertex Pharmaceuticals Incorporated
ISEE / IVERIC bio Inc
TNGX / Tango Therapeutics, Inc.
EXAS / Exact Sciences Corporation
ALNY / Alnylam Pharmaceuticals, Inc.
NTLA / Intellia Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
IPSC / Century Therapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
BLU / Bellus Health Inc
RNA / Atrium Therapeutics, Inc.
SMFR / Sema4 Holdings Corp - Class A
ATEC / Alphatec Holdings, Inc.
PFE / Pfizer Inc.
ACIU / AC Immune SA
ARYD / ARYA Sciences Acquisition Corp IV
ARVN / Arvinas, Inc.
UTHR / United Therapeutics Corporation
LLY / Eli Lilly and Company
CYTT / Cyteir Therapeutics, Inc.
SGEN / Seagen Inc
GRPH / Graphite Bio, Inc.
ACET / Adicet Bio, Inc.
EPIX / ESSA Pharma Inc.
ELV / Elevance Health, Inc.
CTLT / Catalent, Inc.
KROS / Keros Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
CRBU / Caribou Biosciences, Inc.
KZR / Kezar Life Sciences, Inc.
UNH / UnitedHealth Group Incorporated
SCYX / SCYNEXIS, Inc.
BAX / Baxter International Inc.
IDYA / IDEAYA Biosciences, Inc.
KYMR / Kymera Therapeutics, Inc.
NTRA / Natera, Inc.